These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6603688)

  • 1. A function for human T200 in natural killer cytolysis.
    Sparrow RL; McKenzie IF
    Transplantation; 1983 Aug; 36(2):166-71. PubMed ID: 6603688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of human natural killer recognition demonstrated by cloned effector cells and differential blocking of cytotoxicity with monoclonal antibodies.
    Pawelec G; Newman W; Schwulera U; Wernet P
    Cell Immunol; 1985 Apr; 92(1):31-40. PubMed ID: 3865716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes.
    Harris DT; Jaso-Friedmann L; Evans DL
    Immunol Lett; 1993 Sep; 38(1):11-8. PubMed ID: 8300148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against leucoagglutinin-reactive human T lymphocyte surface components. Two antibodies which inhibit cell-mediated cytotoxicity at a post-binding stage.
    Vargas-Cortes M; Hammarström ML; Hammarström S; Hellström U; Perlmann P
    Eur J Immunol; 1986 Jul; 16(7):795-801. PubMed ID: 3522246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.
    Starling GC; Davidson SE; McKenzie JL; Hart DN
    Immunology; 1987 Jul; 61(3):351-6. PubMed ID: 2440797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel antigenic cell surface protein associated with T200 is involved in the post-activation stage of human NK cell-mediated lysis.
    Burns GF; Werkmeister JA; Triglia T
    J Immunol; 1984 Sep; 133(3):1391-6. PubMed ID: 6379048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells.
    Mittler RS; Greenfield RS; Schacter BZ; Richard NF; Hoffmann MK
    J Immunol; 1987 May; 138(10):3159-66. PubMed ID: 2952710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.
    Bridges KR; Smith BR
    J Clin Invest; 1985 Sep; 76(3):913-8. PubMed ID: 2995450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell nature and heterogeneity of recognition structures of human natural killer (NK) cells.
    Fast LD; Beatty P; Hansen JA; Newman W
    J Immunol; 1983 Nov; 131(5):2404-10. PubMed ID: 6415167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
    Helfand SL; Werkmeister J; Roder JC
    J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody against K562 cell line accelerates killing of the target cells by large granular lymphocytes.
    Park MM; Brahmi Z
    Cell Immunol; 1984 Mar; 84(1):94-103. PubMed ID: 6583012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human natural cytotoxic lymphocytes: definition by a monoclonal antibody of a subset which kills an anchorage-dependent target cell line but not the K-562 cell line.
    Rola-Pleszczynski M; Lieu H
    Cell Immunol; 1983 Dec; 82(2):326-33. PubMed ID: 6197190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in normal pregnancy: analysis using monoclonal antibodies and single-cell cytotoxicity assays.
    Gregory CD; Lee H; Rees GB; Scott IV; Shah LP; Golding PR
    Clin Exp Immunol; 1985 Oct; 62(1):121-7. PubMed ID: 3864569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.